Parkinson’s disease is a chronic and progressive condition affecting the brain and nervous system. It impacts millions of ...

Oct. 30, 2024 — The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Nilotinib, a drug approved by the US Food and Drug Administration ... and the International Parkinson and Movement Disorder ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer’s, and Parkinson’s disease continues to rise, especially for MS ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

Some Diabetes Drugs Tied to Lower Risk of Dementia ... Researchers Target Neurogenesis in New Approach to Treat Parkinson's Disease Apr. 30, 2024 — Researchers have found a way to better ...